Anaptysbio (ANAB) Other Working Capital Changes (2016 - 2026)
Anaptysbio (ANAB) posted Other Working Capital Changes of -$499000.0 for Q1 2026, down 1.01% on a QoQ basis from -$494000.0 in Q4 2025, and down 8.01% year-over-year from -$542442.4 in Q1 2025.
Anaptysbio (ANAB) Other Working Capital Changes (2016 - 2026) Analysis & Trends
Anaptysbio's Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$499000.0 for Q1 2026.
- Quarterly Other Working Capital Changes fell 8.01% year-over-year to -$499000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.0 million (down 8.22% YoY) and the FY2025 annual result came in at -$1.9 million, down 8.33% from the prior year.
- Other Working Capital Changes was -$499000.0 for Q1 2026 at Anaptysbio, down from -$494000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $5.8 million in Q3 2023 and bottomed at -$3.1 million in Q2 2024.
- A 5-year average of -$77000.0 and a median of -$414000.0 in 2025 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes plunged 2045.0% — and 2023, when it decreased 7.97%.
- Anaptysbio's Other Working Capital Changes stood at -$389000.0 in 2022, then slipped by 7.97% to -$420000.0 in 2023, then retreated by 8.81% to -$457000.0 in 2024, then decreased by 8.1% to -$494000.0 in 2025, then dropped by 1.01% to -$499000.0 in 2026.
- Business Quant data shows ANAB's Other Working Capital Changes at -$499000.0 in Q1 2026, -$494000.0 in Q4 2025, and -$490000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Anaptysbio | 1.58 Bn | 1.29 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.50 Mn |
| Mar 31, 2026 | -1.50 Mn |
| Mar 31, 2026 | -1.50 Mn |
| Dec 31, 2025 | -971,000.00 |
| Dec 31, 2025 | -971,000.00 |
| Dec 31, 2025 | -971,000.00 |
| Sep 30, 2025 | 303,000.00 |
| Sep 30, 2025 | 303,000.00 |
| Sep 30, 2025 | 303,000.00 |
| Jun 30, 2025 | -414,000.00 |
| Jun 30, 2025 | -414,000.00 |
| Jun 30, 2025 | -414,000.00 |
| Mar 31, 2025 | -530,000.00 |
| Mar 31, 2025 | -530,000.00 |
| Mar 31, 2025 | -530,000.00 |
| Dec 31, 2024 | -299,000.00 |
| Dec 31, 2024 | -299,000.00 |
| Dec 31, 2024 | -299,000.00 |
| Sep 30, 2024 | -1.41 Mn |
| Sep 30, 2024 | -1.41 Mn |